Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 4,220Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6DUCHESNAY

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Immuno-Oncology 360
Not Confirmed
arrow
Immuno-Oncology 360
Not Confirmed

OSPEMIFENE

US Patent Number : 8236861

Drug Substance Claim :

Drug Product Claim :

Application Number : 203505

Patent Use Code : U-905

Delist Requested :

Patent Use Description : TREATMENT OF MODERATE ...

Patent Expiration Date : 2026-08-11

blank

02

arrow
Immuno-Oncology 360
Not Confirmed
arrow
Immuno-Oncology 360
Not Confirmed

OSPEMIFENE

US Patent Number : 8236861

Drug Substance Claim :

Drug Product Claim :

Application Number : 203505

Patent Use Code : U-1369

Delist Requested :

Patent Use Description : TREATMENT OF VAGINAL S...

Patent Expiration Date : 2026-08-11

blank

03

arrow
Immuno-Oncology 360
Not Confirmed
arrow
Immuno-Oncology 360
Not Confirmed

OSPEMIFENE

US Patent Number : 6245819

Drug Substance Claim :

Drug Product Claim :

Application Number : 203505

Patent Use Code : U-905

Delist Requested :

Patent Use Description : TREATMENT OF MODERATE ...

Patent Expiration Date : 2025-07-21

blank

04

arrow
Immuno-Oncology 360
Not Confirmed
arrow
Immuno-Oncology 360
Not Confirmed

OSPEMIFENE

US Patent Number : 6245819

Drug Substance Claim :

Drug Product Claim :

Application Number : 203505

Patent Use Code : U-1370

Delist Requested :

Patent Use Description : TREATMENT OF DYSPAREUN...

Patent Expiration Date : 2025-07-21

blank

05

arrow
Immuno-Oncology 360
Not Confirmed
arrow
Immuno-Oncology 360
Not Confirmed

OSPEMIFENE

US Patent Number : 8236861

Drug Substance Claim :

Drug Product Claim :

Application Number : 203505

Patent Use Code : U-1370

Delist Requested :

Patent Use Description : TREATMENT OF DYSPAREUN...

Patent Expiration Date : 2026-08-11

blank

06

arrow
Immuno-Oncology 360
Not Confirmed
arrow
Immuno-Oncology 360
Not Confirmed

OSPEMIFENE

US Patent Number : 8642079

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 203505

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-07-09

blank